Stock Report

All about this stock under one free report Last Updated: 15-May-2026

Stock Rating

Is this stock worth it? Our ratings reveal the truth.

Wealth Insight New Issue

This month’s issue could change how you invest, read now.

Recently Viewed

Clear All

Heart Test Laboratories Inc. (HSCS)

Stock Card factsheet share-fund-plan-icon

$1.91

up-down-arrow $0.02 (1.06%)

As on 14-May-2026 16:00EDT

Market cap

info icon

$6 Mln

Revenue (TTM)

info icon

$0 Mln

P/E Ratio

info icon

--

P/B Ratio

info icon

2.3

Div. Yield

info icon

0 %

Heart Test Laboratories Inc. (HSCS) Share Price

Compare

High:loading Low:loading Return: loading

Max:loading Min:loading Median:loading

Max:loading Min:loading Median:loading

Price P/E Ratio P/B Ratio

Stock Range

Today’s Range

Low: 1.80 High: 1.91

52 Week Range

Low: 1.80 High: 6.47

Liquidityliquidity Low

Low Moderate High

Fundamentals

  • Net Profit (TTM)Net Profit (TTM) information

    $0 Mln

  • ROEROE information

    -3.8 %

  • ROCEROCE information

    -- %

  • Industry P/EIndustry P/E information

    44.07

  • EV/EBITDAEV/EBITDA information

    -0.1

  • Debt to EquityDebt to Equity information

    0.2

  • Book ValueBook Value information

    $--

  • EPSEPS information

    $--

  • Face valueFace value information

    --

  • Shares outstandingShares outstanding information

    3,184,700

Years Aggregate

CFO

$--

EBITDA

$--

Net Profit

$--

Performance

Company
YTD
1 Month
3 Months
1 Year
3 Years
5 Years
10 Years
Heart Test Laboratories Inc. (HSCS)
-38.2 -4.0 -36.3 -42.6 20.2 -- --
BSE Sensex*
-11.1 -2.1 -8.9 -7.5 6.6 9.1 11.4
S&P Small-Cap 600#
-5.8 -5.3 -13.7 -6.3 5.3 3.0 5.5
As on 14-May-2026  |  *As on 15-May-2026  |  #As on 26-Oct-2023
Company
2025
2024
2023
Heart Test Laboratories Inc. (HSCS)
-19.1 2,078.1 -79.6
S&P Small-Cap 600
4.0 7.0 13.9
BSE Sensex
9.1 8.1 18.7

Essential Checks

View Details

Is there a threat to the company's solvency?

Can creative accounting be detected through the financial numbers?

How did the company perform in the last one year?

Financials

View Details
Quarterly Annual

*All values are in ($ Mln)

Annual

*All values are in ($ Mln)

Annual

*All values are in ($ Mln)

Key Ratios

View Details

5Y Avg -- 3Y Avg -- TTM --

P/E Ratio

--

--Min --Median --Max

P/B Ratio

--

--Min --Median --Max

Earnings Yield (%)

--

Earnings Yield (%) = EBIT / Enterprise value

PEG Ratio

--

Price = Price / Earnings to growth ratio

Peers

View Details
Company
 Price ($) Market Cap ($ Mln) Revenue (TTM) Net Profit (TTM) OPM (%) ROE (%) P/E P/B
Heart Test Laboratories Inc. (HSCS)
1.9 6.2 0.0 -8.5 -89,802.3 -292.9 -- 2.3
Avantor (AVTR)
7.9 5,441.6 6,552.2 -551.4 -4.3 -9.9 -- 1.0
Bio-Rad Laboratories
260.0 6,838.7 2,589.9 168.8 21.4 2.5 42.5 1.0
Bruker (BRKR)
44.2 6,586.8 3,458.5 -10.3 1.9 -0.5 -- 2.7
Glaukos Corp (GKOS)
142.2 7,950.8 551.4 -189.3 -15.6 -26.3 -- 11.7
Lantheus Holdings (LNTH)
96.7 6,124.5 1,546.2 279.0 15.0 23.9 22.5 5.0
Masimo (MASI)
178.4 9,347.9 1,558.5 76.3 19.1 9.5 44.1 11.8
Penumbra (PEN)
323.0 12,653.3 1,454.3 171.1 11.1 12.1 74.1 8.6
Repligen (RGEN)
103.4 6,538.2 763.3 51.4 11.6 2.5 127.4 3.3
Smith & Nephew SNATS - ADR
29.7 12,420.6 6,178.4 626.5 13.0 11.9 20.3 2.4

Shareholding Pattern

View Details
These are advertorial stories which keeps Value Research free for all. Click here to mark your interest for an ad-free experience in a paid plan

About Heart Test Laboratories Inc. (HSCS)

HeartSciences Inc., a medical technology company, focuses on applying AI-based technology to an ECG to expand and improve clinical usefulness. It develops artificial intelligence-enhanced electrocardiography (AI-ECG) solutions, an algorithm to detect...  impaired cardiac relaxation or cardiac dysfunction caused by heart disease and/or age-related cardiac dysfunction; MyoVista wavECG device, a resting 12-lead ECG that provides diagnostic information related to cardiac dysfunction, as well as conventional ECG information in the same test; and MyoVista Insights, a cloud-based platform to host AI-ECG algorithms on an ECG hardware agnostic basis. The company was formerly known as Heart Test Laboratories, Inc. and changed its name to HeartSciences Inc. in October 2024. HeartSciences Inc. was incorporated in 2007 and is headquartered in Southlake, Texas. Address: 550 Reserve Street, Southlake, TX, United States, 76092  Read more

  • CEO, President & Chairman of the Board of Directors

    Mr. Andrew Simpson

  • CEO, President & Chairman of the Board of Directors

    Mr. Andrew Simpson

  • Headquarters

    Southlake, TX

  • Website

    https://heartsciences.com

Value Research Ratings

Our rating system has guided millions of investors in the past 20 years.

Top Rated Stocks

All stocks with 5-star Value Research Ratings

Top Rated Stocks Icon

High Quality Small Caps

Small-cap stocks rated high on quality score

High Quality Small Caps Icon

High Growth Large Caps

Large-cap stocks with a high growth score

High Growth Large Caps Icon

Value Meets Momentum

Top momentum stocks with a high valuation score

Value Meets Momentum Icon

Top Rated Banks

Banks that rate high on Value Research Stock Ratings

Top Rated Banks Icon
Explore Screeners
Edit peer-selector-edit

FAQs for Heart Test Laboratories Inc. (HSCS)

The share price of Heart Test Laboratories Inc (HSCS) is $1.91 (NASDAQ) as of 14-May-2026 16:00 EDT. Heart Test Laboratories Inc (HSCS) has given a return of 20.19% in the last 3 years.

Since, TTM earnings of Heart Test Laboratories Inc (HSCS) is negative, P/E ratio is not available.
The P/B ratio of Heart Test Laboratories Inc (HSCS) is 2.32 times as on 12-May-2026, a 20 discount to its peers’ median range of 2.89 times.


PE & PB ratio at the end of financial year.


Year P/E Ratio P/B Ratio
2025
--
--
2024
--
--
2023
--
--
2022
--
--
2021
--
--

The 52-week high and low of Heart Test Laboratories Inc (HSCS) are Rs 6.47 and Rs 1.80 as of 15-May-2026.

Heart Test Laboratories Inc (HSCS) has a market capitalisation of $ 6 Mln as on 12-May-2026. As per SEBI classification, it is a Small Cap company.

Before investing in Heart Test Laboratories Inc (HSCS), assess your goals, risk tolerance, and if the company aligns with your long-term plan. Carefully review its business model, financials, and valuation. Avoid making decisions based on tips or short-term trends.

For guidance, explore our expert-curated portfolios and Stock recommendations with Value Research Stock Advisor.
Want to explore on your own? Click here to see how this stock scores on quality, growth, valuation, and momentum.